Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer
Ben M. Eyck(Erasmus MC Cancer Institute), J. Jan B. van Lanschot(Erasmus MC Cancer Institute), Daan Nieboer(Erasmus MC), Manon C.W. Spaander(Erasmus University Rotterdam), Barbera D. Onstenk(Erasmus MC), Bo Jan Noordman(Erasmus MC Cancer Institute), Sjoerd M. Lagarde(University of Amsterdam), Bas P. L. Wijnhoven(Erasmus MC Cancer Institute), Roelf Valkema(Active Medicine (United Kingdom))
Cited by 88
Related Papers
Extended Transthoracic Resection Compared with Limited Transhiatal Resection for Adenocarcinoma of the Esophagus
|New England Journal of Medicine|2002|1.6k
A calibration hierarchy for risk models was defined: from utopia to empirical data
|Journal of Clinical Epidemiology|2016|834
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|788
Extended Transthoracic Resection Compared With Limited Transhiatal Resection for Adenocarcinoma of the Mid/Distal Esophagus
|Annals of Surgery|2007|709
A new framework to enhance the interpretation of external validation studies of clinical prediction models
|Journal of Clinical Epidemiology|2014|555